Article Text
PDFResearch ethics
Response
Response to: ‘We could be heroes: ethical issues with the pre-recruitment of research participants’ by D. Hunter
Statistics from Altmetric.com
I am happy that my paper provoked a response from the Health Research Authority (HRA) and that they have taken the opportunity to clarify this area—I want to respond in part to some of their comments, while accepting that some are accurate.1 ,2
While I am gladdened that generic advertising must now be submitted for review for stage 1 clinical trials since 2013 (there was some crossover between the original conception of the paper and this time period), I have to say this is at best only partially reassuring.
First, …
Footnotes
Twitter Follow David Hunter at @idmonfish
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- We could be heroes: ethical issues with the pre-recruitment of research participants
- Response to: ‘We could be heroes: ethical issues with the pre-recruitment of research participants’ by Hunter
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- Can an ethics officer role reduce delays in research ethics approval? A mixed-method evaluation of an improvement project
- Research ethics committee decision-making in relation to an efficient neonatal trial
- Beyond regulatory approaches to ethics: making space for ethical preparedness in healthcare research
- Introducing patient and public involvement practices to healthcare research in Austria: strategies to promote change at multiple levels
- Implementation of the EU clinical trial regulation transforms the ethics committee systems and endangers ethical standards
- Proportional ethical review and the identification of ethical issues
- Registration audit of clinical trials given a favourable opinion by UK research ethics committees